Document is current
Any future updates will be listed below
-
Authors
Bergeron, Sophie
Reed, Barbara D.
Wesselmann, Ursula
Bohm-Starke, Nina
- License Information
-
More Information
Article History
Accepted: 19 March 2020
First Online: 30 April 2020
Competing interests
: U.W. serves on the External Consultant Board for the NIH Preclinical Screening Platform for Pain, a novel preclinical pain therapy screening platform that has been launched at the National Institute for Neurological Disorders and Stroke as part of the NIH Helping to End Addiction Long-term Initiative. In her capacity as a special government employee of the FDA, U.W. has served as a voting member of the FDA Anaesthetic and Analgesic Drug Products Advisory Committee. U.W. has served as a consultant for Grünenthal GmbH and Ironwood Pharmaceuticals, Inc. All other authors declare no competing interests.
